申请人:Merck & Co. Inc.
公开号:US05663175A1
公开(公告)日:1997-09-02
Certain prodrugs such as ##STR1## are useful in the inhibition of herpes virus thymidine kinase, the prevention or treatment of recurrent infection by herpes virus, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of preventing or treating recurrent infection by herpes virus are also described.
某些前药,如##STR1##,在抑制疱疹病毒胸苷激酶、预防或治疗疱疹病毒复发感染方面具有用处,无论是作为化合物、药用盐、药用成分,还是与其他抗病毒药物、免疫调节剂、抗生素或疫苗组合使用。还描述了预防或治疗疱疹病毒复发感染的方法。